Navigation Links
Joseph E. Whitters Joins MyoScience, Inc. Board of Directors
Date:6/25/2009

REDWOOD CITY, Calif., June 25 /PRNewswire/ -- MyoScience(R), Inc. today announced that Joseph E. Whitters, CPA former chairman of the board of Mentor Corporation, was elected to the MyoScience board of directors. Whitters joined the Mentor board in 2004, assuming the Chairman role soon thereafter. Mentor was acquired by Johnson and Johnson (JNJ) in 2009 for $1.1 Billion. He also serves on the boards of directors of Omnicell, Luminent Mortgage Capital, and several private companies. From 1986 to 2005, Mr. Whitters was an executive at First Health, serving as CFO for most of his tenure. During that period the company's revenues grew from $5 to $900 Million. It was acquired by Coventry Health Plans in 2005 for $1.8 Billion.

"Joe Whitters has an exceptionally strong financial and operational background. Additionally, he has a deep industry experience in the health care and aesthetics areas. This very relevant experience and his critical insight into the aesthetics market will greatly benefit a company at MyoScience's stage," said Bob Curtis, MyoScience CEO.

"I believe MyoScience has some very innovative and unique aesthetics technologies," said Whitters. "I look forward to working with this dynamic team and the board."

Whitters will fill a board seat left vacant by the stepping down of Michael Partsch, CEO of Accelemed, Inc., who has been a board member since MyoScience's initial funding. Mr. Partsch will remain a board observer.

"MyoScience has made great strides since its initial funding," said Michael Partsch. "I am honored to have been part of that success as a board member and am very excited about the opportunity available to the Company".

"Mike Partsch has been a valuable board member since our A round of financing," said Bob Curtis. "We thank him for his seminal contributions to the early success of MyoScience."

About MyoScience, Inc.

MyoScience, Inc., founded in 2005 with headquarters in Redwood City, California, is a clinical development stage company focused on developing a non-toxic treatment for dynamic facial wrinkles (frown lines between the brows and forehead and crow's feet lines). MyoScience received 510k clearance from the U.S. Food and Drug Administration for its device in 2009 for a general indication. MyoScience is currently investigating applications in aesthetics. Major investors in MyoScience, include De Novo Ventures, Accuitive Medical Ventures, Nexus Medical Partners, Saratoga Ventures, and Medicis Capital GmbH.

    Press Contacts:
    Robert M. Curtis, President and CEO
    MyoScience, Inc.
    bcurtis@myoscience.com
    (650) 474-2600


'/>"/>
SOURCE MyoScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
2. Dr. Joseph Sweere Receives Educator of the Year Award
3. St. Josephs Hospital and Medical Center Signs Agreement for Innovative Video Conferencing Use
4. Statement by Joseph A. Califano, Jr., Chairman and Founder, The National Center on Addiction and Substance Abuse at Columbia University and Former U.S. Secretary of Health, Education, and Welfare, on New Report by the National Association of Boards of Pha
5. Joseph C. Kolars, M.D., to be U-M Medical Schools First Senior Associate Dean for Education and Global Initiatives
6. St. Josephs Healthcare System Becomes First Hospital in the Region to Implement Pre-Hospital Therapeutic Cooling to Save the Lives of Cardiac Arrest Patients
7. Statement by Joseph A. Califano, Jr., Chairman and President, The National Center on Addiction and Substance Abuse at Columbia University and Former U.S. Secretary of Health, Education and Welfare on New York States Action Council
8. Craneware and St. Joseph to Present Revenue Enhancement Success Story at HIMSS
9. Closing Open Heart Surgery: Saint Josephs Performs Georgias First Totally-Closed, Beating Heart Bypass Surgery
10. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
11. Fischer Medical Announces Multi-System VersaRad Installation at St. Josephs Hospital in Marshfield, WI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD ... New York City. He is known for his distinguished expertise and experience in the ... Benvenisty holds sub-specialty training in treating renovascular disease and aortic aneurysm . He ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Patients who ... Cortland, OH, can now meet with Dr. Joseph Bedich for a consultation, with or ... simultaneously improving their oral health and functionality. , Dr. Bedich offers a ...
(Date:5/24/2017)... Lehi, Utah (PRWEB) , ... May 24, 2017 , ... ... “Super Sick Kids: The Surprising Truth about Pediatric Septic Shock” hosted by the Journal ... 31, 2017, at 2 p.m. Eastern time, will be presented by Captain Rommie Duckworth, ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... Axiad IDS , a ... CIO Applications magazine has named the company a “Top 25 Cybersecurity Companies 2017.” ... Cloud to help organizations simply and proactively address potential cybersecurity threats before they happen. ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/15/2017)... , May 15, 2017  Amy Baxter MD, ... industry leader in noninvasive pain relief, was awarded a ... magazine. Baxter was recognized at the MM&M Top ... New York City on May 10, 2017. ... the biopharma industry go "beyond the pill."  ...
(Date:5/11/2017)... May 11, 2017  Thornhill Research Inc. ( ... awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract ... Canadian Commercial Corporation (CCC) ( Ottawa, Ontario, ... to administer general anesthesia to patients requiring emergency ... "The US Marine Corps have been a longtime ...
Breaking Medicine Technology: